Cardiovascular system

Recipharm invests in Brexit preparations

‘Brexit taskforce’ will see Recipharm prioritise its preparations and invest in the necessary capabilities and equipment to ensure seamless operations post March 2019.

31 May 2018

Patch-in-a-Can technology to delivery pain management product

MedPharm licenses its MedSpray ‘Patch-in-a-Can’ technology to Virpax Pharmaceuticals.

21 Jun 2018

First FDA approval of marijuana-based drug

Approval for seizures associated with Lennox-Gastaut Syndrome or Dravet Syndrome, two rare, severe childhood-onset epilepsies.

26 Jun 2018

Cambrex to expand generic API R&D capabilities at Milan, Italy site

Company to increase the number of generic APIs in the company's development pipeline.

New finished product manufacturing hub in the Middle East

Forgotten markets of Africa and Arabia to see increased growth fuelled by international and domestic partnerships and imported APIs.

Innovative coating process for tablet manufacturers

The Wear Indicator Layer is expected to have a "huge impact" on customers' production.

NURONORM

NURONORM, is a combination of natural elements, based on Alpha-Lipoic acid, Carnosine, Zinc and Vitamin B with clinical trials showing efficacy in the prevention and treatment of (diabetic) neuropathy. NURONORM® can also be used in Peripheral Neuropathies: due to compression, trauma, inflammation, resulti...

DERMOGEL NEW to treat inflammatory skin conditions

Corticosteroids productsClobetasol Propionate 0.05%This products are used in short courses to treat inflammatory skin conditions such as
Eczema of various types.Skin inflammation due to allergies or irritants (allergic contact dermatitis orirritant contact dermatitis).Inflammatory skin co...

Anlitin (Levonorgestrel 1.5 mg) Tablet

Ingredient: Levonorgestrel 1.5 mg
Dosage Form: Tablet

Indication: Emergency Oral ContraceptivesbrhrbrSynmosa Group offers a wide range of oral contraceptive products which includes anlitin. Indication: emergency oral contraceptives. Dosage: 1 tab as soon as poss...